Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial

Published 2016 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
Authors
Keywords
Sitagliptin, Fat mapping, MRI-proton-density-fat-fraction (PDFF), Lipid lowering therapy, NAFLD, Hepatic steatosis, Non-alcoholic steatohepatitis, Non-invasive assessment, Magnetic resonance elastography, Imaging, Biomarker, Fibrosis
Journal
JOURNAL OF HEPATOLOGY
Volume 65, Issue 2, Pages 369-376
Publisher
Elsevier BV
Online
2016-05-03
DOI
10.1016/j.jhep.2016.04.021

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.